Home › Parkinson's Disease › New York › New York City
Parkinson's Disease clinical trials in New York City, NY
23 studies for Parkinson's Disease are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
RecruitingPhase 2
- Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York
- Columbia University, New York
Visual Hallucinations in Lewy Body Diseases
RecruitingObservational studyHealthy volunteers welcome
- NYU Langone Health, New York
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
RecruitingPhase 2/3
- Site-005, New York
GBPDC: Gut-Brain in PD Consortium Master Protocol
RecruitingObservational studyHealthy volunteers welcome
- Columbia University, New York
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
RecruitingPhase 2
- Weill Cornell Medical College, New York
A Study of Buntanetap in Participants With PD
RecruitingPhase 2/3
- Mount Sinai Hospital, New York
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RecruitingPhase 2
- Vima Site #024, New York
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
RecruitingPhase 2
- Joan and Sanford I. Weill Department of Medicine (Site #224), New York
- Mount Sinai School of Medicine (Site #209), New York
Parkinson's Foundation PD GENEration Genetic Registry
RecruitingObservational study
- Mount Sinai, New York
- Columbia University, New York
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
RecruitingObservational study
- Northwell Health, New York
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RecruitingPhase 3
- Weill Cornell Medical College, New York
- Columbia University Medical Center, New York
Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
RecruitingObservational studyHealthy volunteers welcome
- NYU Langone Health, New York
Autoimmune Features of Neurodegenerative Disorders
RecruitingObservational studyHealthy volunteers welcome
- Columbia University Medical Center, New York
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
RecruitingPhase 3
- Mount Sinai West - Neurology, New York
- New York Presbyterian/Weill Cornell Medical Center, New York
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
Recruiting
- Radial Midtown Manhattan, New York
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RecruitingObservational studyHealthy volunteers welcome
- Beth Israel Medical Center, New York
- NYU Langone Health, New York
Natural History Study of Synucleinopathies
RecruitingObservational study
- NYU Medical Center, New York
Parkinson's Disease Biomarkers in Nerve Cells in the Gut
RecruitingObservational studyHealthy volunteers welcome
- Weill Cornell Medicine, New York
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
RecruitingPhase 1/2
- Cornell University Weill Medical College, New York
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
RecruitingObservational study
- Weill Cornell Medicine, New York
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
RecruitingPhase 1/2
- New York Presbyterian Hospital-Columbia University Medical Center, New York
NYSCF Scientific Discovery Biobank
RecruitingObservational study
- New York Stem Cell Foundation Research Institute, New York
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
RecruitingEarly phase 1
- Teachers College, Columbia University, New York
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- Boston, MA19 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN15 studies
- Philadelphia, PA14 studies
- San Francisco, CA14 studies
- New Haven, CT14 studies
- Charleston, SC13 studies
- Farmington Hills, MI13 studies
- Chicago, IL13 studies
- Miami, FL13 studies
- Aurora, CO12 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.